| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/10/2013 | US20130011487 Fluorinated block co-polymers |
| 01/10/2013 | US20130011473 Preparation Method Of The Solid Formulation Of Clopidogrel Bisulfate |
| 01/10/2013 | US20130011472 Stable pharmaceutical composition and methods of using same |
| 01/10/2013 | US20130011471 Stable pharmaceutical composition and methods of using same |
| 01/10/2013 | US20130011453 Buffered microencapsulated compositions and methods |
| 01/10/2013 | US20130011451 Footbed with non-denatured collagen |
| 01/10/2013 | US20130011405 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 01/10/2013 | US20130011390 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 01/10/2013 | US20130011382 Fibrinogen Preparations Enriched In Fibrinogen With An Extended Alpha Chain |
| 01/10/2013 | US20130011371 ESTABLISHMENT OF PATIENT- OR PERSON- SPECIFIC CARDIAC MYOCYTE CELL LINES FROM HUMAN INDUCED PLURIPOTENT STEM CELLS (iPSCs) |
| 01/10/2013 | US20130011361 Pyrazole derivatives which modulate stearoyl-coa desaturase |
| 01/10/2013 | CA2840876A1 Formulations that stabilize proteins |
| 01/09/2013 | EP2543679A1 Antibodies for the treatment and prevention of thrombosis |
| 01/09/2013 | EP2543678A1 Antibodies for the treatment and prevention of thrombosis |
| 01/09/2013 | EP2543677A1 Antibodies for the treatment and prevention of thrombosis |
| 01/09/2013 | EP2543676A1 Cyclical tripeptide mimetics |
| 01/09/2013 | EP2543369A2 Solution for peritoneal dialysis |
| 01/09/2013 | EP2542529A1 Urethanes, ureas, amidines and related inhibitors of factor xa |
| 01/09/2013 | EP2542255A1 Methods and compositions for treating degos' disease |
| 01/09/2013 | CN1642570B Stable pharmaceutical composition containing factor viii |
| 01/09/2013 | CN102869362A Vitamin-containing nutrition infusion for administration through peripheral vein |
| 01/09/2013 | CN102863531A CD20-resistant monoclonal antibody as well as preparation method and application thereof |
| 01/09/2013 | CN102863457A Optically-active 2- hydroxyltetrathienopyridine derivative, preparation method thereof and application of optically-active 2- hydroxyltetrathienopyridine derivative to pharmacy |
| 01/09/2013 | CN102861323A A novel blood substitute with complete red blood cell functions |
| 01/09/2013 | CN102861322A Hemoglobin-based oxygen carrier and preparation method thereof |
| 01/09/2013 | CN102861315A Preparation method of casein anticoagulant peptide oral liquid |
| 01/09/2013 | CN102861252A Blood-cooling and heat-removing tablet |
| 01/09/2013 | CN102861244A Traditional Chinese medicine compound for treating cardia-cerebrovascular disease |
| 01/09/2013 | CN102861225A Radix ophiopogonis yin-nourishing and liquid engendering tablets |
| 01/09/2013 | CN102861198A Pure traditional Chinese medicine preparation for treating cirrhosis with ascites |
| 01/09/2013 | CN102861194A Liver clearing capsules |
| 01/09/2013 | CN102861140A Method for preparing total paeony glycoside |
| 01/09/2013 | CN102861137A Origin processing and quality maintaining, packing and storing method for rheum officinale |
| 01/09/2013 | CN102861135A Extraction method of buckwheat flavonoids |
| 01/09/2013 | CN102861104A Method and device for treating in-vitro blood |
| 01/09/2013 | CN102861024A Application of Gypensapogenin A in medicine for increasing white blood cell |
| 01/09/2013 | CN102861012A Medicine composition containing 18 amino acids and preparation thereof |
| 01/09/2013 | CN102406945B Fluorocarbon and cyclodextrin inclusion compound and preparation method thereof |
| 01/09/2013 | CN102379883B Pharmaceutical composition of glycerin fructose injection |
| 01/09/2013 | CN102343100B Method for quickly preparing rutin inclusion compound |
| 01/09/2013 | CN102258690B Chinese medicinal composition for treating duodenal hemorrhage and hemorrhage of digestive tract |
| 01/09/2013 | CN102151255B Application of resveratrol in preparing medicines for preventing and treating radiation-induced bone marrow suppression |
| 01/09/2013 | CN102138945B Method of extracting active substances with high content of flavones from ginkgo leaves |
| 01/09/2013 | CN102120744B Optical-activity 2-hydroxytetrahydrothienopyridine derivative, preparation method and application thereof in pharmacy |
| 01/09/2013 | CN102106831B 地西他滨冻干制剂及其制备方法 Decitabine lyophilized formulation and preparation method |
| 01/09/2013 | CN101969953B Pterin analog for treating bh4 responsive condition |
| 01/09/2013 | CN101953986B Method for preparing Chinese medicinal preparation for treating Qi deficiency and blood deficiency |
| 01/09/2013 | CN101787078B Collagen polypeptide, preparation method and application thereof |
| 01/09/2013 | CN101647563B Compound black-bone chicken honeyed pill and preparation method thereof |
| 01/09/2013 | CN101402642B Novel environment friendly preparation method for prasugrel |
| 01/09/2013 | CN101400655B Quinolone derivative or pharmaceutically acceptable salt thereof |
| 01/09/2013 | CN101337988B New erythrocyte-stimulating factor analogues |
| 01/09/2013 | CN101255149B 7,4'-di(mono succinate)o-ethoxy-daidzein and novel medical uses thereof |
| 01/08/2013 | US8349862 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 01/08/2013 | CA2617510C Use of iron (iii) complex compounds for the preparation of a medicament for oral treatment of iron deficiency states in patients with chronic inflammatory bowel disease |
| 01/08/2013 | CA2582262C Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| 01/08/2013 | CA2507710C Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 01/08/2013 | CA2490121C Modified phospholipids |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/05/2013 | CA2745267A1 Iron supplement composition |
| 01/03/2013 | WO2013003808A1 Methods for modulating kallikrein (klkb1) expression |
| 01/03/2013 | WO2013003045A2 Procoagulant peptides and their derivatives and uses therefor |
| 01/03/2013 | WO2013001890A1 Soyasapogenol composition |
| 01/03/2013 | WO2013001544A1 Anti-thrombotic compounds |
| 01/03/2013 | WO2012141536A9 Composition for regenerating connective tissue, and method for regenerating connective tissue |
| 01/03/2013 | US20130007926 Administration of plant expressed oral tolerance agents |
| 01/03/2013 | US20130005834 Pharmaceutical compositions containing substituted 6-deoxy-6-sulfanylcyclodextrin |
| 01/03/2013 | US20130005784 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 01/03/2013 | US20130005782 Method for integrin ligand discovery |
| 01/03/2013 | US20130005781 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 01/03/2013 | US20130005778 Urethanes, ureas, amidines and related inhibitors of factor xa |
| 01/03/2013 | US20130005742 Substituted Diphenylpyrazine Derivatives |
| 01/03/2013 | US20130005724 Pyridino-pyridinone derivatives, preparation and therapeutic use thereof |
| 01/03/2013 | US20130005707 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith |
| 01/03/2013 | US20130005704 Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors |
| 01/03/2013 | US20130005701 Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/03/2013 | US20130005699 Methods and products for treatment of diseases |
| 01/03/2013 | US20130005687 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
| 01/03/2013 | US20130005685 Starch derivative mixtures |
| 01/03/2013 | US20130005683 Glycine betaine and its use |
| 01/03/2013 | US20130005658 Micro-rna regulation in ischemia and ischemia-reperfusion injury |
| 01/03/2013 | US20130005657 SYNERGISTIC THERAPEUTIC USE OF PROTHROMBIN COMPLEX CONCENTRATES WITH FVlll CONCENTRATES |
| 01/03/2013 | US20130005656 Modified Factor VIII |
| 01/03/2013 | US20130005645 Apoe peptide dimers and uses thereof |
| 01/03/2013 | US20130004598 Herbal Preparation for Anemia and a Manufacture Method Thereof |
| 01/03/2013 | US20130004572 Stable pharmaceutical composition and methods of using same |
| 01/03/2013 | US20130004551 Biotinylated hexadecasaccharides, preparation and use thereof |
| 01/03/2013 | US20130004526 Utilization of Dialkylfumarates |
| 01/03/2013 | US20130004524 Conjugated Proteins |
| 01/03/2013 | US20130004507 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 01/03/2013 | US20130004478 Procoagulant Peptides and Their Derivatives and Uses Therefor |
| 01/03/2013 | US20130004473 Methods and Biomarkers for the Detection of Dengue Hemorrhagic Fever |
| 01/03/2013 | US20130004467 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 01/03/2013 | US20130004465 Adherent cells from placenta and use of same in disease treatment |
| 01/03/2013 | US20130004462 Modified factor viii and factor ix genes and vectors for gene therapy |
| 01/03/2013 | US20130004452 Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof |
| 01/03/2013 | US20130004428 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/03/2013 | CA2840614A1 Methods for modulating kallikrein (klkb1) expression |
| 01/03/2013 | CA2840290A1 Procoagulant peptides and their derivatives and uses therefor |